Lead Product(s) : Methohexital
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Health Research Board, Ireland
Deal Size : Inapplicable
Deal Type : Inapplicable
Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression
Details : Methohexitone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Depression.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 24, 2013
Lead Product(s) : Methohexital
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Health Research Board, Ireland
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
